Transcenta Holding Limited (6628.HK)
HKD 0.6
(0.0%)
HKD 0.6
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -1.14 CNY | -17.53% |
| 2022 | -0.97 CNY | 89.61% |
| 2021 | -9.34 CNY | -1162.16% |
| 2020 | -0.74 CNY | 24.49% |
| 2019 | -0.98 CNY | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -0.16 CNY | 42.86% |
| 2024 Q2 | -0.16 CNY | 0.0% |
| 2023 Q1 | -0.29 CNY | -20.83% |
| 2023 FY | - CNY | -17.53% |
| 2023 Q4 | -0.28 CNY | 0.0% |
| 2023 Q3 | -0.28 HKD | 3.45% |
| 2023 Q2 | -0.29 CNY | 0.0% |
| 2022 Q2 | -0.23 CNY | 0.0% |
| 2022 Q1 | -0.23 CNY | 82.84% |
| 2022 FY | - CNY | 89.61% |
| 2022 Q4 | -0.24 CNY | 0.0% |
| 2022 Q3 | -0.24 CNY | -4.35% |
| 2021 Q3 | -1.34 CNY | 37.09% |
| 2021 Q4 | -1.34 CNY | 0.0% |
| 2021 Q2 | -2.13 CNY | -1231.25% |
| 2021 Q1 | -0.16 CNY | 88.24% |
| 2021 FY | - CNY | -1162.16% |
| 2020 Q1 | -0.06 CNY | 0.0% |
| 2020 FY | - CNY | 24.49% |
| 2020 Q4 | -1.36 CNY | 0.0% |
| 2020 Q3 | -1.36 CNY | -580.0% |
| 2020 Q2 | -0.20 CNY | -259.71% |
| 2019 FY | - CNY | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 0.01 HKD | 10370.27% |
| CK Life Sciences Int'l., (Holdings) Inc. | 0.00 HKD | 63433.333% |